Nearly 200 X-Ray Crystal Structures of Transthyretin: What Do They Tell Us About This Protein and the Design of Drugs for TTR Amyloidoses?

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|19|15|2324-2342

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.19, Iss.15, 2012-04, pp. : 2324-2342

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Small Transthyretin (TTR) Ligands as Possible Therapeutic Agents in TTR Amyloidoses

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 4, Iss. 5, 2005-10 ,pp. : 587-596

Bentham Science Publishers

Access to resources Recommend Favorite

What Heroin Users Tell Us About Overdose

By Baca Catherine T.   Grant Kenneth J.  

Journal of Addictive Diseases, Vol. 26, Iss. 4, 2007-08 ,pp. : 63-68

Haworth Press

Access to resources Recommend Favorite

X-ray structural information of GPCRs in drug design: what are the limitations and where do we go?

By Topiol Sid  

Expert Opinion on Drug Discovery, Vol. 8, Iss. 6, 2013-10 ,pp. : 607-620

Informa Healthcare

Access to resources Recommend Favorite

Polymorphisms in dopamine receptors: what do they tell us?

By Hung Choy Wong A.   Buckle C.E.   Van Tol H.H.M.  

European Journal of Pharmacology, Vol. 410, Iss. 2, 2000-12 ,pp. : 183-203

Elsevier

Access to resources Recommend Favorite

Protein Kinase C Isozyme Selective Peptides - A Current View of What they Tell Us About Location and Function of Isozymes in the Heart

By  

Current Pharmaceutical Design, Vol. 11, Iss. 4, 2005-02 ,pp. : 549-559

Bentham Science Publishers

Access to resources Recommend Favorite